Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment

Eline G M van Geffen,Joost Nederend,Tania C Sluckin,Sanne-Marije J A Hazen,Karin Horsthuis,Regina G H Beets-Tan,Corrie A M Marijnen,Pieter J Tanis,Miranda Kusters,Dutch Snapshot Research Group,Arend G J Aalbers,Susanna M van Aalten,Femke J Amelung,Marjolein Ankersmit,Imogeen E Antonisse,Jesse F Ashruf,Tjeerd S Aukema,Henk Avenarius,Renu R Bahadoer,Frans C H Bakers,Ilsalien S Bakker,Fleur Bangert,Renée M Barendse,Heleen M D Beekhuis,Geerard L Beets,Willem A Bemelman,Maaike Berbée,Shira H de Bie,Robert H C Bisschops,Robin D Blok,Liselotte W van Bockel,Anniek H Boer,Frank C den Boer,Evert-Jan G Boerma,Leonora S F Boogerd,Jaap Borstlap,Wernard A A Borstlap,Johanna E Bouwman,Sicco J Braak,Manon N G J A Braat,Jennifer Bradshaw,Amarins T A Brandsma,Vivian van Breest Smallenburg,Wim T van den Broek,Sjirk W van der Burg,Jacobus W A Burger,Thijs A Burghgraef,David W G Ten Cate,Heleen M Ceha,Jeltsje S Cnossen,Robert R J Coebergh van den Braak,Esther C J Consten,Maaike Corver,Rogier M P H Crolla,Sam Curutchet,Alette W Daniëls-Gooszen,Paul H P Davids,Emmelie N Dekker,Jan Willem T Dekker,Ahmet Demirkiran,Tyche Derksen,Arjen L Diederik,Anne M Dinaux,Kemal Dogan,Ilse M van Dop,Kitty E Droogh-de Greve,Hanneke M H Duijsens,Michalda S Dunker,Johan Duyck,Eino B van Duyn,Laurentine S E van Egdom,Bram Eijlers,Youssef El-Massoudi,Saskia van Elderen,Anouk M L H Emmen,Marc Engelbrecht,Anne C van Erp,Jeroen A van Essen,Hans F J Fabry,Thomas Fassaert,Eline A Feitsma,Shirin S Feshtali,Bas Frietman,Edgar J B Furnée,Anne M van Geel,Elisabeth D Geijsen,Anna A W van Geloven,Michael F Gerhards,Hugo Gielkens,Renza A H van Gils,Lucas Goense,Marc J P M Govaert,Wilhelmina M U van Grevenstein,E Joline de Groof,Irene de Groot,Robbert J de Haas,Nadia A G Hakkenbrak,Mariska D den Hartogh,Vera Heesink,Joost T Heikens,Ellen M Hendriksen,Sjoerd van den Hoek,Erik J R J van der Hoeven,Christiaan Hoff,Anna Hogewoning,Cornelis R C Hogewoning,Stefan Hoogendoorn,Francois van Hoorn,René L van der Hul,Rieke van Hulst,Farshad Imani,Bas Inberg,Martijn P W Intven,Pedro Janssen,Chris E J de Jong,Jacoline Jonkers,Daniela Jou-Valencia,Bas Keizers,Stijn H J Ketelaers,Eva Knöps,Sebastiaan van Koeverden,Sylvia Kok,Stephanie E M Kolderman,Fleur I de Korte,Robert T J Kortekaas,Julie C Korving,Ingrid M Koster,Jasenko Krdzalic,Pepijn Krielen,Leonard F Kroese,Eveline J T Krul,Derk H H Lahuis,Bas Lamme,An A G van Landeghem,Jeroen W A Leijtens,Mathilde M Leseman-Hoogenboom,Manou S de Lijster,Martijn S Marsman,MilouH Martens,Ilse Masselink,Wout van der Meij,Philip Meijnen,Jarno Melenhorst,Dietrich J L de Mey,Julia Moelker-Galuzina,Linda Morsink,Erik J Mulder,Karin Muller,Gijsbert D Musters,Peter A Neijenhuis,Lindsey C F de Nes,M Nielen,Jan B J van den Nieuwboer,Jonanne F Nieuwenhuis,Joost Nonner,Bo J Noordman,Stefi Nordkamp,Pim B Olthof,Steven J Oosterling,Daan Ootes,Vera Oppedijk,Pieter Ott,Ida Paulusma,Koen C M J Peeters,Ilona T A Pereboom,Jan Peringa,Zoë Pironet,Joost D J Plate,Fatih Polat,Ingrid G M Poodt,Lisanne A E Posma,Jeroen F Prette,Bareld B Pultrum,Seyed M Qaderi,Jan M van Rees,Rutger-Jan Renger,Anouk J M Rombouts,Lodewijk J Roosen,Ellen A Roskott-Ten Brinke,Joost Rothbarth,Dennis B Rouw,Tom Rozema,Heidi Rütten,Harm J T Rutten,Marit E van der Sande,Boudewijn E Schaafsma,Renske A Schasfoort,Merel M Scheurkogel,Arjan P Schouten van der Velden,Wilhelmina H Schreurs,Puck M E Schuivens,Colin Sietses,Petra C G Simons,Marjan J Slob,Gerrit D Slooter,Martsje van der Sluis,Bo P Smalbroek,Anke B Smits,Ernst J Spillenaar-Bilgen,Patty H Spruit,Tanja C Stam,Jaap Stoker,Aaldert K Talsma,Sofieke J D Temmink,G Y Mireille The,Jeroen A W Tielbeek,Aukje A J M van Tilborg,Fiek van Tilborg,Dorothée van Trier,Jurriaan B Tuynman,Maxime J M van der Valk,Inge J S Vanhooymissen,G Boudewijn C Vasbinder,Cornelis J Veeken,Laura A Velema,Anthony W H van de Ven,Emiel G G Verdaasdonk,Wouter M Verduin,Tim Verhagen,Paul M Verheijen,Maarten Vermaas,An-Sofie E Verrijssen,Anna V D Verschuur,Harmke Verwoerd-van Schaik,Roy F A Vliegen,Sophie Voets,F Jeroen Vogelaar,Clementine L A Vogelij,Johanna Vos-Westerman,Marianne de Vries,Joy C Vroemen,Bas S T van Vugt,Johannes A Wegdam,Bob J van Wely,Marinke Westerterp,Paul P van Westerveld,Henderik L van Westreenen,Allard G Wijma,Johannes H W de Wilt,Bart W K de Wit,Fennie Wit,Karlijn Woensdregt,Victor van Woerden,Floor S W van der Wolf,Sander van der Wolk,Johannes M Wybenga,Edwin S van der Zaag,Bobby Zamaray,Herman J A Zandvoort,Dennis van der Zee,Annette P Zeilstra,Kang J Zheng,David D E Zimmerman,Marcel Zorgdrager

DOI: https://doi.org/10.1016/j.ejso.2024.108307

Abstract:Background: Detection of grade 3-4 extra mural venous invasion (mrEMVI) on magnetic resonance imaging (MRI) is associated with an increased distant metastases (DM)-rate. This study aimed to determine the impact of different grades of mrEMVI and their disappearance after neoadjuvant therapy. Methods: A Dutch national retrospective cross-sectional study was conducted, including patients who underwent resection for rectal cancer in 2016 from 60/69 hospitals performing rectal surgery. Patients with a cT3-4 tumour ≤8 cm from the anorectal junction were selected and their MRI-scans were reassessed by trained abdominal radiologists. Positive mrEMVI grades (3 and 4) were analyzed in regard to 4-year local recurrence (LR), DM, disease-free survival (DFS) and overall survival (OS). Results: The 1213 included patients had a median follow-up of 48 months (IQR 30-54). Positive mrEMVI was present in 324 patients (27%); 161 had grade 3 and 163 had grade 4. A higher mrEMVI stage (grade 4 vs grade 3 vs no mrEMVI) increased LR-risk (21% vs 18% vs 7%, <0.001) and DM-risk (49% vs 30% vs 21%, p < 0.001) and decreased DFS (42% vs 55% vs 69%, p < 0.001) and OS (62% vs 76% vs 81%, p < 0.001), which remained independently associated in multivariable analysis. When mrEMVI had disappeared on restaging MRI, DM-rate was comparable to initial absence of mrEMVI (both 26%), whereas LR-rate remained high (22% vs 9%, p = 0.006). Conclusion: The negative oncological impact of mrEMVI on recurrence and survival rates was dependent on grading. Disappearance of mrEMVI on restaging MRI decreased the risk of DM, but not of LR.